SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK bioscience and KDCA join forces to build a national pandemic preparedness and response system for potential next-pandemic avian influenza. "We will...

menu
menu